| Full Name | Aware Inc |
|---|---|
| Speciality | Clinic/Center |
| Location | 205 E Park Ave, Anaconda, Montana |
| Authorized Official Name and Position | Leslie A York (BUSINESS OPERATIONS MANAGER) |
| Authorized Official Contact | 4065638117 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Aware Inc 205 E Park Ave Anaconda MT 59711-2340 Ph: (406) 563-8117 | Aware Inc 205 E Park Ave Anaconda MT 59711-2340 Ph: (406) 563-8117 |
| NPI Number | 1427003862 |
|---|---|
| Provider Enumeration Date | 05/24/2006 |
| Last Update Date | 11/19/2021 |
| Certification Date | 11/19/2021 |
| Medicare PECOS PAC ID | 4284529348 |
|---|---|
| Medicare Enrollment ID | O20040224000994 |
News Archive
A first-of-its-kind study of gene therapy in the treatment of Parkinson's disease determined that half of all patients who received the treatment had "clinically meaningful improvements" of their symptoms within six months of surgery.
Tenofovir, one of the most effective and commonly prescribed antiretroviral medications for HIV/AIDS, is associated with a significant risk of kidney damage and chronic kidney disease that increases over time, according to a study of more than 10,000 patients led by researchers at the San Francisco VA Medical Center and the University of California, San Francisco (UCSF).
A new study, led by RCSI researchers, has found that patients receiving methadone treatment are most at risk of overdosing in the month following the end of methadone treatment and during the first four weeks of treatment.
Because Caucasians have a higher skin cancer risk than the general population, people with skin of color may believe that they don't need to be concerned about this disease — but new research reveals this to be a dangerous misconception.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427003862 | NPI | - | NPPES |
| 0502299 | Medicaid | MT | |
| 0290343 | Medicaid | MT | |
| 0320255 | Medicaid | MT | |
| 0047124 | Medicaid | MT | |
| 690812 | Medicaid | MT | |
| 92507255 | Medicaid | NM | |
| 0320331 | Medicaid | MT | |
| 0493119 | Medicaid | MT | |
| 000744813 | Other | MT | BCBS PRE-LIC'D PROFESSNLS |
| 0255374 | Medicaid | MT | |
| B3373 | Medicaid | NM | |
| 0350812 | Medicaid | MT | |
| NM600001 | Other | NM | VALUEOPTIONS VENDOR ID |
| Provider Name | Susan F Depasquale |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1063827202 PECOS PAC ID: 4183844871 Enrollment ID: I20140930003110 |
News Archive
A first-of-its-kind study of gene therapy in the treatment of Parkinson's disease determined that half of all patients who received the treatment had "clinically meaningful improvements" of their symptoms within six months of surgery.
Tenofovir, one of the most effective and commonly prescribed antiretroviral medications for HIV/AIDS, is associated with a significant risk of kidney damage and chronic kidney disease that increases over time, according to a study of more than 10,000 patients led by researchers at the San Francisco VA Medical Center and the University of California, San Francisco (UCSF).
A new study, led by RCSI researchers, has found that patients receiving methadone treatment are most at risk of overdosing in the month following the end of methadone treatment and during the first four weeks of treatment.
Because Caucasians have a higher skin cancer risk than the general population, people with skin of color may believe that they don't need to be concerned about this disease — but new research reveals this to be a dangerous misconception.
› Verified 9 days ago
| Provider Name | Jill Dee Buck |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1720711567 PECOS PAC ID: 7517343023 Enrollment ID: I20221006003404 |
News Archive
A first-of-its-kind study of gene therapy in the treatment of Parkinson's disease determined that half of all patients who received the treatment had "clinically meaningful improvements" of their symptoms within six months of surgery.
Tenofovir, one of the most effective and commonly prescribed antiretroviral medications for HIV/AIDS, is associated with a significant risk of kidney damage and chronic kidney disease that increases over time, according to a study of more than 10,000 patients led by researchers at the San Francisco VA Medical Center and the University of California, San Francisco (UCSF).
A new study, led by RCSI researchers, has found that patients receiving methadone treatment are most at risk of overdosing in the month following the end of methadone treatment and during the first four weeks of treatment.
Because Caucasians have a higher skin cancer risk than the general population, people with skin of color may believe that they don't need to be concerned about this disease — but new research reveals this to be a dangerous misconception.
› Verified 9 days ago
| Provider Name | Katherine T Bugni |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1093483968 PECOS PAC ID: 0547632655 Enrollment ID: I20230217000686 |
News Archive
A first-of-its-kind study of gene therapy in the treatment of Parkinson's disease determined that half of all patients who received the treatment had "clinically meaningful improvements" of their symptoms within six months of surgery.
Tenofovir, one of the most effective and commonly prescribed antiretroviral medications for HIV/AIDS, is associated with a significant risk of kidney damage and chronic kidney disease that increases over time, according to a study of more than 10,000 patients led by researchers at the San Francisco VA Medical Center and the University of California, San Francisco (UCSF).
A new study, led by RCSI researchers, has found that patients receiving methadone treatment are most at risk of overdosing in the month following the end of methadone treatment and during the first four weeks of treatment.
Because Caucasians have a higher skin cancer risk than the general population, people with skin of color may believe that they don't need to be concerned about this disease — but new research reveals this to be a dangerous misconception.
› Verified 9 days ago
| Provider Name | Samantha Alicia Reed |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1285318394 PECOS PAC ID: 8628431855 Enrollment ID: I20230905003716 |
News Archive
A first-of-its-kind study of gene therapy in the treatment of Parkinson's disease determined that half of all patients who received the treatment had "clinically meaningful improvements" of their symptoms within six months of surgery.
Tenofovir, one of the most effective and commonly prescribed antiretroviral medications for HIV/AIDS, is associated with a significant risk of kidney damage and chronic kidney disease that increases over time, according to a study of more than 10,000 patients led by researchers at the San Francisco VA Medical Center and the University of California, San Francisco (UCSF).
A new study, led by RCSI researchers, has found that patients receiving methadone treatment are most at risk of overdosing in the month following the end of methadone treatment and during the first four weeks of treatment.
Because Caucasians have a higher skin cancer risk than the general population, people with skin of color may believe that they don't need to be concerned about this disease — but new research reveals this to be a dangerous misconception.
› Verified 9 days ago
News Archive
A first-of-its-kind study of gene therapy in the treatment of Parkinson's disease determined that half of all patients who received the treatment had "clinically meaningful improvements" of their symptoms within six months of surgery.
Tenofovir, one of the most effective and commonly prescribed antiretroviral medications for HIV/AIDS, is associated with a significant risk of kidney damage and chronic kidney disease that increases over time, according to a study of more than 10,000 patients led by researchers at the San Francisco VA Medical Center and the University of California, San Francisco (UCSF).
A new study, led by RCSI researchers, has found that patients receiving methadone treatment are most at risk of overdosing in the month following the end of methadone treatment and during the first four weeks of treatment.
Because Caucasians have a higher skin cancer risk than the general population, people with skin of color may believe that they don't need to be concerned about this disease — but new research reveals this to be a dangerous misconception.
› Verified 9 days ago
Carly Hillenbrand Aprn, Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 200 Main St, Anaconda, MT 59711 Phone: 406-209-7777 | |
Sherri Bell, Lcsw, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 118 E 7th St, Anaconda, MT 59711 Phone: 406-560-3959 | |
Melissa Riley Counselingllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 18 Cedar St, Anaconda, MT 59711 Phone: 406-560-2467 | |
Gypsy Ray Lcsw Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 118 E 7th St Ste 2d, Anaconda, MT 59711 Phone: 406-880-0977 |